Serum Phosphate and Calcium Should Be Primarily and Consistently Controlled in Prevalent Hemodialysis Patients-Reference-Cited by-同舟云学术

Serum Phosphate and Calcium Should Be Primarily and Consistently Controlled in Prevalent Hemodialysis Patients

Published:2013-04 Issue:2 Volume:17 Page:221-228
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:Ther Apher Dial

Author:

Taniguchi Masatomo¹,Fukagawa Masafumi²,Fujii Naohiko³,Hamano Takayuki⁴,Shoji Tetsuo⁵,Yokoyama Keitaro⁶,Nakai Shigeru⁷,Shigematsu Takashi⁸,Iseki Kunitoshi⁹,Tsubakihara Yoshiharu⁴,

Affiliation:

1. Departments of Medicine and Clinical Science; Graduate School of Medical, Sciences; Kyushu University; Fukuoka

2. Division of Nephrology, Endocrinology and Metabolism; Tokai University School of Medicine; Kanagawa

3. Medical and Research Center for Nephrology and Transplantation; Hyogo Prefectural Hospital; Hyogo

4. Department of Comprehensive Kidney Disease Research; Osaka University Graduate School of Medicine; Osaka

5. Department of Metabolism, Endocrinology, and Molecular Medicine; Division of Kidney and Hypertension; Osaka City University; Graduate School of Medicine; Osaka

6. Department of Internal Medicine; Jikei University School of Medicine; Tokyo

7. Fujita Health University School of Medic; Aichi

8. Division of Nephrology and Blood Purification Medicine; Department of Medicine; Wakayama Medical University; Wakayama

9. Dialysis Unit; University Hospital of the Ryukyu; Okinawa; Japan

Publisher

Wiley

Subject

Nephrology,Hematology

Reference37 articles.

1. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: improving Global Outcomes (KDIGO);Moe;Kidney Int,2006

2. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney failure;National Kidney Foundation;Am J Kidney Dis,2003

3. The Kidney Disease Outcomes Quality Initiative (K/DOQI) guideline for bone metabolism and disease in CKD: association with mortality in dialysis patients;Noodzij;Am J Kidney Dis,2005

4. Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity;Wang;Am J Kidney Dis,1995

5. Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients;Guideline Working Group, Japanese Society for Dialysis Therapy;Ther Apher Dial,2008

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calcium-Phosphorus Product Is Associated with Adverse Prognosis in Hospitalized Patients with Heart Failure and Chronic Kidney Disease;International Heart Journal;2024-01-31

2. Phosphate and Coronary Artery Disease in Patients with Chronic Kidney Disease;Journal of Atherosclerosis and Thrombosis;2024-01-01

3. Alkaline Phosphatase and Parathyroid Hormone Levels: International Variation and Associations With Clinical Outcomes in the DOPPS;Kidney International Reports;2024-01

4. Clinical Implication of Consistently Strict Phosphate Control for Coronary and Valvular Calcification in Incident Patients Undergoing Hemodialysis;Journal of Atherosclerosis and Thrombosis;2023-11-01

5. Tenapanor for the Treatment of Hyperphosphatemia in Japanese Hemodialysis Patients: A Randomized Phase 3 Monotherapy Study With an Up-titration Regimen;American Journal of Kidney Diseases;2023-11